FTC’s Misguided Antitrust Regulation Threatens Pharma Innovation

On December 11 of last year, the Federal Trade Commission filed suit to block a partnership between Sanofi and Maze Pharmaceuticals to develop a drug for Pompe disease, a partnership that the government said “threaten[ed] to deprive patients of a new, innovative treatment.”